# Norges Bank Investment Management

> Norges Bank Investment Management is a VC fund backing Health Care. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Oslo, Norway
- Total investments: 7
- Last investment: Jul 2026
- Lead investor: 14%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/norges-bank-investment-management/
- Website: https://www.nbim.no/en
- Facebook: https://www.facebook.com/StatensPensjonsfondUtland/

Norges Bank Investment Management is a VC fund in Oslo focused on Health Care and Biotechnology. Norges Bank Investment Management is the asset management unit of the Norwegian central bank (Norges Bank). They manage the Government Pension Fund Global, often referred to as the Norwegian oil fund, and some of Norges Bank's foreign exchange reserves.Norges Bank Investment Management aims to get the highest possible return on the fundwithin the investment mandate set by the Ministry of Finance. They seek to safeguard the long-term financial interests of Norway's future generations through active management and active ownership.

## Contacts

5 contacts available for Norges Bank Investment Management. Shizune tracks 4 team members at Norges Bank Investment Management. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/norges-bank-investment-management?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 29% |
| Biotechnology | 2 | 29% |
| Manufacturing | 2 | 29% |
| CRM | 1 | 14% |
| Energy | 1 | 14% |

28 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 2 | 29% |
| Post-IPO Equity | 2 | 29% |
| Post-IPO Secondary | 2 | 29% |
| Secondary Market | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 3 | 43% |
| Norway | 1 | 14% |
| Denmark | 1 | 14% |
| Germany | 1 | 14% |
| United States | 1 | 14% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Mikko Korhonen | Senior Trader | 0 | — |
| Nicolai Tangen | Chief Executive Officer | 0 | — |
| Pål Sundsøy | Lead Researcher & Equity Strategies | 0 | — |
| Yngve Slyngstad | CEO | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Biocon | Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. From discovery to development and commercialisation, Biocon has the defining science, cost-effective drug development capabilities and significant manufacturing capacity to move ideas to market. | $382M | Post-IPO Secondary | Jul 13, 2026 |  |
| ECHO Realty | ECHO Realty is a commercial real estate company that develops, acquires, owns, leases, and manages grocery-anchored retail properties and shopping centers. The company focuses on necessity-based retail real estate, working with grocery stores and complementary retail tenants to create and operate community-oriented shopping destinations. Itsservices encompass the full property lifecycle, including acquisitions, development, redevelopment, leasing, property management, construction management, and investment partnership management. The company manages a portfolio of retail properties that include grocery-anchored shopping centers, multi-tenant retail centers, mixed-use developments, convenience retail locations, and other commercial real estate assets. It evaluates and acquires both stabilized and value-add retail properties while also undertaking redevelopment projects to enhance property performance and tenant mix. |  | Private Equity | Jun 05, 2026 |  |
| Emcure Pharmaceuticals | Emcure was born out of the vision to create a healthcare company that would address the vast healthcare needs. They commitment and drive have propelled our growth from a single manufacturing facility during the genesis, to a range of world class manufacturing facilities spread across API, formulations and biotechnology.Headquartered in Pune,India, Emcure is today a vertically integrated pharmaceutical company with infrastructure, skills and resources that are at par with the best in the world. Our strengths span research to the manufacturing of APIs, Formulations and Biotechnology.The Company has carved a niche for itself as a preferred outsourcing partner for some of the largest MNCs both in India and global markets. | $30.4M | Post-IPO Secondary | Apr 29, 2026 |  |
| TenneT Germany | TenneT is a leading European grid operator. We are committed to providing a secure and reliable supply of electricity 24 hours a day, 365 days a year, while helping to drive the energy transition in our pursuit of a brighter energy future – more sustainable, reliable and affordable than ever before. In our role as the first cross-borderTransmission System Operator (TSO) we design, build, maintain and operate 24,500 kilometres of high-voltage electricity grid in the Netherlands and large parts of Germany, and facilitate the European energy market through our 16 interconnectors to neighbouring countries. We are one of the largest investors in national and international onshore and offshore electricity grids, with a turnover of EUR 6.4 billion and a total asset value of EUR 32 billion. Every day our 6,600 employees take ownership, show courage and make and maintain connections to ensure that the supply and demand of electricity is balanced for over 42 million people. | $11.2B | Private Equity | Sep 24, 2025 |  |
| DSV | DSV is a transport and logistics firm that provides transportation services worldwide by road, air, sea, and train, with the majority of its business coming from its European trucking network and airfreight and sea freight forwarding divisions. The company was founded in 1976 and is headquartered in Hedehusene, Hovedstaden, Denmark. | $5.5B | Post-IPO Equity | Oct 04, 2024 |  |
| Deepak Fertilisers | Deepak Fertilisers is a manufacturing agency that produces fertilizers and industrial chemicals. | $68M | Post-IPO Equity | Oct 22, 2021 |  |
| Visma | Visma provides business software and services for accounting and administration. The group comprises three divisions: Software SMB (SW SMB), Software Government & Large Accounts (SW GLA), and Business Process Outsourcing (BPO). |  | Secondary Market | Sep 10, 2021 |  |

7 of 7 investments shown.

## Co-investors
- Axis Mutual Fund — VC Fund, 2 deals together
- [GIC](https://shizune.co/investors/profile/gic) — VC Fund, 2 deals together
- [Societe Generale S.A.](https://shizune.co/investors/profile/societe-generale) — VC Fund, 2 deals together
- [Abakkus](https://shizune.co/investors/profile/abakkus) — VC Fund, 1 deal together
- Aditya Birla Sunlife Mutual Fund — VC Fund, 1 deal together
- Aeternum Management — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

## FAQ

### What does Norges Bank Investment Management invest in?

Norges Bank Investment Management invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Private Equity and Post-IPO Equity stage. Most of the 7 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Norges Bank Investment Management?

Public channels for Norges Bank Investment Management include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Norges Bank Investment Management?

The team at Norges Bank Investment Management includes Mikko Korhonen (Senior Trader), Nicolai Tangen (Chief Executive Officer) and Pål Sundsøy (Lead Researcher & Equity Strategies). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co